Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-07 | New | $4,665,479 | $4,665,479 | Equity Only | 06b | SEC link |
| 2025-04-10 | New | Yet to Sell | $0 | Equity Only | 06b | SEC link |
| 2024-03-06 | New | $3,000,000 | $3,000,000 | Debt Only | 06b | SEC link |
| 2022-12-15 | Amended | $19,336,491 | $8,166,491 | Equity Only | 06b | SEC link |
| 2022-10-19 | New | $11,170,000 | $11,170,000 | Equity Only | 06b | SEC link |
| 2020-12-10 | New | $14,482,301 | $14,482,301 | Equity Only | 06b | SEC link |
| 2019-11-14 | Amended | $6,500,000 | $2,557,460 | Equity Only | 06b | SEC link |
| 2019-10-15 | New | $3,942,540 | $3,942,540 | Equity Only | 06b | SEC link |
| 2019-05-13 | New | $21,886,833 | $21,886,833 | Equity Only | 06b | SEC link |
| 2018-09-12 | New | $4,025,000 | $4,025,000 | Debt Only | 06b | SEC link |
| 2017-03-20 | New | $3,000,000 | $3,000,000 | Equity Only | 06b | SEC link |
| 2017-02-03 | New | $150,000 | $150,000 | Debt Only | 06b | SEC link |
| 2015-10-08 | New | $410,000 | $410,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Alex Andrianopoulos | Director |
| Neil Bajpayee | Director |
| Aaron G.L. Fletcher | Director |
| Aaron Glenn Louis Fletcher | Director |
| Jason Keyes | Director |
| Leslie Wayne Kreis Jr. | Director |
| Leslie Kreis, Jr. | Director |
| Pascal Krotee | Director |
| Paul Lytle | Executive |
| Andrew Mazar | Executive |
| Amy Ronneberg | Director |
| Roger Sawhney | Director |
| Daniel Schmitt | Director, Executive |
| Todd Thomson | Director |
| Dan Zabrowski | Director |
| Daniel Zabrowski | Director |